ARAY: Kapitalisasi marang pendapatan Accuray Inc
The development of exclusive CyberKnife robots allows Accuray Incorporated (ARAY) to implement premium pricing. On GURU.Markets, the company's rolling P/S captures the impact of this strategy, where 0.00 shapes the current metric. A stable brand image within the oncology community and low sensitivity to macroeconomic shocks, driven by long-term government equipment procurement, ensure the resilience of the asset's quotes.
Rincian analitis perusahaan Accuray Inc. (ARAY)
- nilai saham lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Accuray Incorporated|ARAY - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Accuray, Inc.|ARAY - Gunggung utang perusahaan|Utang-utang marang nilai buku Accuray Inc.|ARAY - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Accuray Incorporated|Koefisien jangkoan perantara accuray.com
- data bathi bisnis lan rasio investasi:
ARAY - Bathi resik perusahaan|Prakiraan bathi resik Accuray Incorporated|ARAY - Pangali P/E|Prakiraan rega marang bathi Accuray Inc|ARAY - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Accuray Inc.|ARAY - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Accuray Incorporated|ARAY - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan accuray.com|ARAY - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Accuray Incorporated
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:ARAY - accuray.com
The P/S multiple determines the market value of Accuray Incorporated relative to its annual sales volume, measuring the premium investors are willing to pay per unit of revenue. By analyzing the price-to-sales ratio, one can assess the fairness of the capitalization of this high-tech business, where the value of CyberKnife systems and the precision of radiosurgery should be reflected in the company's valuation dynamics relative to industry standards.
Karo sapa Accuray Incorporated saingan
Multiplikator P/S beigene.com (ONC)|Multiplikator P/S HALO (Halozyme)|RVMD - Kapitalisasi marang pendapatan|Ascentage - Multiplikator P/S|CG Oncology Therapeutics (CGON) - Kapitalisasi marang pendapatan|URGN (UroGen Pharma Ltd.) - Kapitalisasi marang pendapatan|bicara.com (BCAX) - Multiplikator P/S|Rasio rega marang pendapatan Personalis|ERAS: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DCTH|Multiplikator P/S Y-mAbs Corp (YMAB)|Aura Biosciences, Inc. - Kapitalisasi marang pendapatan|Candel Therapeutics Inc. (CADL) - Rega marang dodolan|SLS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ACTU (Actuate Therapeutics Inc.)|CTOR: Multiplikator P/S|HURA - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Protara Therapeutics|Rasio kapitalisasi marang pendapatan FATE (fatetherapeutics.com)|Multiplikator P/S WHWK|Kapitalisasi marang pendapatan tscan.com TCRX|Rasio rega marang pendapatan Champions Oncology, Inc. CSBR|XBiotech Inc (XBIT) - Rega marang dodolan|CVM - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OSTX (ostherapies.com)|Radiopharm Theranostics (RADX) - Rasio rega marang pendapatan|Rasio rega marang dodolan ARTV (Artiva Biotherapeutics)|Rasio rega marang pendapatan Adlai Nortye Ltd|Rega marang dodolan Veru Corporation VERU|Rasio rega marang pendapatan Tempest Therapeutics (TPST)|XLO (xiliotx.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S RENB (Renovaro)|Multiplikator P/S Mural Oncology PLC MURA|KAPA: Kapitalisasi marang pendapatan|OnKure Therapeutics Inc - Kapitalisasi marang volume dodolan|GDTC: Multiplikator P/S|Rega marang dodolan Curis (CRIS)|APLM (Apollomics Inc.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan THAR (Tharimmune Inc)|Multiplikator P/S ADVB|Multiplikator P/S Genprex Inc (GNPX)|Rasio rega marang pendapatan Calidi Biotherapeutics, Inc. CLDI|Rasio kapitalisasi pasar marang pendapatan SBFM|Xenetic Bio - Multiplikator P/S|SLRX - Multiplikator P/S|PPBT (Purple Biotech Corp) - Kapitalisasi marang pendapatan|Rega marang dodolan American Oncology Network, Inc. (AONC)|BGNE (BeiGene, Ltd.) - Multiplikator P/S|Kapitalisasi marang pendapatan checkpointtx.com (CKPT)|Multiplikator P/S ELEV|Multiplikator P/S icadmed.com (ICAD)|Rasio rega marang pendapatan Ikena Oncology IKNA|NTBL: Rasio kapitalisasi marang pendapatan|Viracta - Multiplikator P/S|morphosys.com (MOR) - Kapitalisasi marang pendapatan|NAYA: Multiplikator P/S|Rega marang dodolan Ascentage Pharma Group International (AAPGV)
